synchron series khosla venturesparkfiercebiotech

Synchron raises $40M to trial neurotech that helps paralysis patients text, email and shop online

Synchron, After years of focused on everything AI, the most talked-about topics in medical technology today are not robots and algorithms but rather the uniquely non-artificial capabilities of the human brain. The FDA has just issued both a “leapfrog” recommendation and a ground-breaking approval for these brain-computer interfaces, a sci-fi-like family of technologies that scan…

Read More